Detalhe da pesquisa
1.
Building an innovative Chagas disease program for primary care units, in an urban non- endemic city.
BMC Public Health
; 19(1): 904, 2019 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31286922
2.
Reporting of adverse reactions to benznidazole: does medical expertise matter?
Rev Panam Salud Publica
; 42: e69, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-31093097
3.
Systematic Review and Meta-analysis of the Pharmacokinetics of Benznidazole in the Treatment of Chagas Disease.
Antimicrob Agents Chemother
; 60(12): 7035-7042, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27550362
4.
Mother-to-child Chagas disease transmission: The challenge of detection and prevention in areas without the risk of vectorial transmission.
Int J Gynaecol Obstet
; 164(3): 835-842, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37493222
5.
Pharmacokinetic Characterization and Comparative Bioavailability of an Innovative Orodispersible Fixed-Dose Combination of Ivermectin and Albendazole: A Single Dose, Open Label, Sequence Randomized, Crossover Clinical Trial in Healthy Volunteers.
Front Pharmacol
; 13: 914886, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35910353
6.
Safety and Pharmacokinetic Assessments of a Novel Ivermectin Nasal Spray Formulation in a Pig Model.
J Pharm Sci
; 110(6): 2501-2507, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493479
7.
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial.
EClinicalMedicine
; 37: 100959, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34189446
8.
Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]".
EClinicalMedicine
; 39: 101119, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462733
9.
NGcGM3 ganglioside: a privileged target for cancer vaccines.
Clin Dev Immunol
; 2010: 814397, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21048926
10.
A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool.
Am J Trop Med Hyg
; 102(2s): 3-24, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31971144
11.
Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers.
PLoS Negl Trop Dis
; 12(1): e0006020, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29346388
12.
Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A community-based pragmatic study.
PLoS Negl Trop Dis
; 11(10): e0006003, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28991899
13.
Voices of biotech leaders.
Nat Biotechnol
; 39(6): 654-660, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34113035
14.
Publisher Correction: Voices of biotech leaders.
Nat Biotechnol
; 39(8): 1017, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290438
15.
Reporting of adverse reactions to benznidazole: does medical expertise matter?
Rev Panam Salud Publica
; 42, mayo 2018
Artigo
em Inglês
| PAHOIRIS | ID: phr-34983
16.
Reporting of adverse reactions to benznidazole: does medical expertise matter? / Notificación de las reacciones adversas al benznidazol: ¿importa la pericia médica? / Notificação de reações adversas ao benznidazol: experiência médica faz diferença?
Rev. panam. salud pública
; 42: e69, 2018. tab
Artigo
em Inglês
| LILACS | ID: biblio-961748
17.
The BENEFIT Trial: Where Do We Go from Here?
PLoS Negl Trop Dis
; 10(2): e0004343, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26913759